Anzeige
Mehr »
Login
Donnerstag, 07.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus" in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
1.434 Leser
Artikel bewerten:
(2)

The Power Play by The Market Herald Releases New Interviews with Eloro Resources, Prospera, Datametrex, Gamelancer Media, Infinity Stone Ventures and PreveCeutical Medical Discussing Their Latest News

VANCOUVER, BC / ACCESSWIRE / November 23, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Eloro Resources, Prospera, Datametrex, Gamelancer Media, Infinity Stone Ventures and PreveCeutical Medical discussing their latest news.

The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

Eloro (TSXV:ELO) significantly expands holdings at the Iska Iska Silver-Tin Polymetallic Project

The Market Herald, Wednesday, November 23, 2022, Press release picture

Eloro (ELO) will acquire the Mina Casiterita and Mina Hoyada properties next to its Iska Iska Project in Bolivia. The properties collectively cover 14.75 km2 southwest and west of Iska Iska. Following the acquisition, the total land package in the Iska Iska area to be controlled by Eloro will total 1,935 quadrants covering 483.75 km2. Bill Pearson, Executive VP of Exploration, spoke with Sabrina Cuthbert about the news.

For the full interview with Bill Peterson and to learn about Eloro, click here.

Prospera Energy (TSXV:PEI) achieves record profitability in Q3

The Market Herald, Wednesday, November 23, 2022, Press release picture

Prospera Energy (PEI) is announcing record profitability for Q3 2022. Revenue came in at $3,752,046, up from $982,966 in Q3 2021. Net income was $938,968, up from ($1,270,030) in Q3 2021. The company will now focus on a Q4 development plan based on the drilling and completion results of two re-entry horizontal pilot wells. CEO Samuel David sat down with Sabrina Cuthbert to discuss the results.

For the full interview with Samuel David and to learn about Prospera Energy, click here.

Datametrex AI (TSXV:DM) reports quarterly Q3 financial results

The Market Herald, Wednesday, November 23, 2022, Press release picture

Datametrex AI Limited (DM) has reported its financial results for the third quarter. $9.2 million in revenue earned during Q3 and over $27.5M in revenue in nine months. Increased AI and Tech revenue of over $3.78M in nine months, up 16 per cent vs. the previous year. Increased Q3 net income of over $961K, up 464 per cent compared to the previous year. Marshall Gunter, CEO of Datametrex, sat down with Sabrina Cuthbert to discuss the results.

For the full interview with Marshall Gunter and to learn about Datametrex AI Limited, click here.

Gamelancer's (CSE:GMNG) owned & operated network exceeds 34 million followers

The Market Herald, Wednesday, November 23, 2022, Press release picture

Gamelancer's community of 27 channels has surpassed 34 million followers on TikTok, Instagram and Snapchat. Gamelancer's (GMNG) @Gaming channel on TikTok has reached 10 million followers. @Gaming on TikTok has also amassed over 486 million likes since the network launched in 2019. President & Chief Operating Officer of Gamelancer Media, Mike Cotton, sat down with Sabrina Cuthbert to discuss the numbers.

For the full interview with Mike Cotton and to learn about Gamelancer's, click here.

Infinity Stone Ventures (CSE:GEMS) hits graphite on Rockstone step-out hole

The Market Herald, Wednesday, November 23, 2022, Press release picture

Infinity Stone Ventures (GEMS) has provided an update on its fall drill program at the Rockstone Graphite Project. The company has completed drilling of the RS-22-03 step-out drillhole, intersecting four separate intervals comprising a total of 45.5 metres of semi-massive to massive graphite. The drill program has been expanded with an additional drill hole. CEO Zayn Kalyan sat down with Sabrina Cuthbert to provide insights on the results.

For the full interview with Zayn Kalyan and to learn about Infinity Stone Ventures, click here.

PreveCeutical (CSE:PREV) files an application for D-amino acid peptides

The Market Herald, Wednesday, November 23, 2022, Press release picture

PreveCeutical (PREV) files a PCT (Patent Cooperation Treaty) application for D-amino acid peptides. The patent aims to seek protection for certain peptides comprising D-amino acids and their use in treating brain cancer. This patent application is made to protect the peptides comprising D-amino acids identified in the BSV research project. CEO Stephen Van Deventer sat down with Sabrina Cuthbert to discuss the news.

For the full interview with Stephen Van Deventer and to learn about PreveCeutical, click here.

Interviews for The Power Play by The Market Herald are released daily. To learn more about the companies featured in The Power Play or to explore our other interviews visit?The Power Play by The Market Herald.

About The Market Herald

The Market Herald Canada is the leading source of authoritative breaking stock market news for self-directed investors. Our team of Canadian markets reporters, editors and technologists covers the entire listed company universe in Canada. We cover over 3,985 businesses, their people, their investors, and their customers. We write the stories that move the Canadian capital markets.

DISCLAIMER: Report Card Canada Media Ltd. ("Report Card") is a wholly-owned subsidiary of Market Herald Limited, an Australian company ("Market Herald"). Report Card is not an advisory service, and does not offer, buy, sell, or provide any other rating, analysis or opinion on the securities we discuss. We are retained and compensated by the companies that we provide information on to assist them with making information available to the public. All information available on themarketherald.ca and/or this press release should be considered as commercial advertisement and not an endorsement, offer or recommendation to buy or sell securities. Report Card is not registered with any financial or securities regulatory authority in any province or territory of Canada, will not be performing any registerable activity as defined by the applicable regulatory bodies and do not provide nor claim to provide investment advice or recommendations to any visitor of this site or readers of any content on or originating from themarketherald.ca. Market Herald and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Market Herald's affiliates. In such instances, Market Herald and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Market Herald and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize any conflict. All the information on this document and/or the website - themarketherald.ca - is published in good faith and for general information purpose only. Report Card does not make any warranties about the completeness, reliability, and accuracy of this information. Any action you take upon the information you find on this document and/or website (themarketherald.ca) is strictly at your own risk. Report Card will not be liable for any losses and/or damages in connection with the use of our website. From our website, you can visit other websites by following hyperlinks to such external sites. While we strive to provide only quality links to useful and ethical websites, we have no control over the content and nature of these sites. These links to other websites do not imply a recommendation for all the content found on these sites. Site owners and content may change without notice and may occur before we have the opportunity to remove a link which may have gone 'bad'. Please be also aware that when you leave our website, other sites may have different privacy policies and terms which are beyond our control. Please be sure to check the Privacy Policies of these sites as well as their "Terms of Service" before engaging in any business or uploading any information.

CONTACT:

The Market Herald
marketing@themarketherald.ca
themarketherald.ca

SOURCE:?The Market Herald

View source version on accesswire.com:
https://www.accesswire.com/728158/The-Power-Play-by-The-Market-Herald-Releases-New-Interviews-with-Eloro-Resources-Prospera-Datametrex-Gamelancer-Media-Infinity-Stone-Ventures-and-PreveCeutical-Medical-Discussing-Their-Latest-News

© 2022 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.